- Home
- RGP vs INMB Comparison
RGP vs INMB Comparison
Compare RGP & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGP
- INMB
- Stock Information
- Founded
- RGP 1996
- INMB 2015
- Country
- RGP United States
- INMB United States
- Employees
- RGP N/A
- INMB N/A
- Industry
- RGP Business Services
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- RGP Consumer Discretionary
- INMB Health Care
- Exchange
- RGP Nasdaq
- INMB Nasdaq
- Market Cap
- RGP 178.9M
- INMB 176.5M
- IPO Year
- RGP 2006
- INMB 2019
- Fundamental
- Price
- RGP $5.14
- INMB $7.62
- Analyst Decision
- RGP Sell
- INMB Strong Buy
- Analyst Count
- RGP 1
- INMB 3
- Target Price
- RGP $5.00
- INMB $24.33
- AVG Volume (30 Days)
- RGP 183.3K
- INMB 339.5K
- Earning Date
- RGP 07-17-2025
- INMB 07-31-2025
- Dividend Yield
- RGP 9.52%
- INMB N/A
- EPS Growth
- RGP N/A
- INMB N/A
- EPS
- RGP N/A
- INMB N/A
- Revenue
- RGP $560,189,000.00
- INMB $50,000.00
- Revenue This Year
- RGP N/A
- INMB N/A
- Revenue Next Year
- RGP $3.85
- INMB N/A
- P/E Ratio
- RGP N/A
- INMB N/A
- Revenue Growth
- RGP N/A
- INMB N/A
- 52 Week Low
- RGP $4.81
- INMB $4.32
- 52 Week High
- RGP $12.19
- INMB $10.50
- Technical
- Relative Strength Index (RSI)
- RGP 43.36
- INMB 52.03
- Support Level
- RGP $5.05
- INMB $7.27
- Resistance Level
- RGP $5.34
- INMB $8.05
- Average True Range (ATR)
- RGP 0.19
- INMB 0.43
- MACD
- RGP 0.01
- INMB 0.01
- Stochastic Oscillator
- RGP 46.15
- INMB 58.10
About RGP Resources Connection Inc.
Resources Connection Inc provides consulting and business initiative support services predominantly through its operative subsidiary, Resources Global Professionals. It has two segments RGP ( Resources Global Professionals.) and Sitrick. The RGP segment is focused on delivering consulting services catering to its client's operational needs and change initiatives utilizing a combination of bench and on-demand, talent. The Sitrick segment provides corporate, financial, transactional, and crisis communication and management services. The company generates a majority of its revenue from the RGP segment. Geographically, it derives its key revenue from North America and the rest from Europe and the Asia Pacific region.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.